Sound Check-Correlation Between Transperineal and Digital Cervical Exam in 3rd Trimester Pregnancy

Sponsor
Baylor College of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT05260333
Collaborator
(none)
30
1
2
3.8
7.8

Study Details

Study Description

Brief Summary

The primary purpose of this study is to compare the accuracy of the Butterfly iQ pocket ultrasound with the digital cervical examination in the third trimester cervix. The secondary aim of this study is to compare discomfort or the two cervical exam methods and determine if patients have a preference for one over the other.

Condition or Disease Intervention/Treatment Phase
  • Device: Butterfly iQ transperineal ultrasound exam
N/A

Detailed Description

Patients in the 3rd trimester that require a digital cervical exam (DCE) for assessment of labor will be approached. After informed consent is obtained, one of two study investigators will perform a transperineal ultrasound (TPUS) using the glove-covered Butterfly iQ+ probe. The Butterfly iQ+ does not have a transperineal probe or setting, therefore, the "bladder" preset setting will be used. The "bladder" setting has been predetermined to provide the best cervical images. This pocket ultrasound is FDA-approved and is the standard of care for point of care ultrasounds in many institutions and is already used in our department. The TPUS will be performed by 1 of the 2 investigators with digital calipers. There will be 3 measurements: dilation, effacement, and station. The dilation measurements with be made from the inside margins of the cervix . Effacement will be measured by marking the thinnest and most easily imaged lip of the cervix. Zero station will be assumed to be 5 cm above the perineum, with distances from 6-10 cm corresponding to -1 to -5 station clinically. An independent, blinded examiner will then perform a traditional digital cervical exam, which will be recorded in EPIC. The study investigators will be blinded to the DCE measurement until the end of the study. The patient will act as their own control. Additionally, the investigators will collect EGA, race, ethnicity, age, BMI, and indication for assessment of the cervix.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Patients will have a transperineal ultrasound followed by a traditional digital cervical exam.Patients will have a transperineal ultrasound followed by a traditional digital cervical exam.
Masking:
Single (Investigator)
Masking Description:
The investigator will not know the digital cervical exam value.
Primary Purpose:
Diagnostic
Official Title:
Sound Check-Correlation Between Transperineal and Digital Cervical Exam Using a Pocket Ultrasound in 3rd Trimester Pregnancy
Actual Study Start Date :
Apr 1, 2022
Actual Primary Completion Date :
Jul 27, 2022
Actual Study Completion Date :
Jul 27, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Transperineal ultrasound cervical exam

Patients will undergo transperineal cervical exam via Butterfly iQ ultrasound.

Device: Butterfly iQ transperineal ultrasound exam
Transperineal ultrasound

Active Comparator: Digital (manual) cervical exam

Patients will undergo traditional digital cervical exam via examiner's fingers.

Device: Butterfly iQ transperineal ultrasound exam
Transperineal ultrasound

Outcome Measures

Primary Outcome Measures

  1. Correlation of cervical dilation and length via Butterfly iQ pocket ultrasound in centimeters [9 months]

    Compared to digital cervical exam

Secondary Outcome Measures

  1. Discomfort scale [9 months]

    5-point Likert scale (0 = no discomfort, 4 = maximum) discomfort on questionnaire

  2. Preference for 1 exam over the other [9 months]

    Circle yes or no on questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Pregnant women in the third trimester presenting for assessment of labor or admitted for labor and delivery.
Exclusion Criteria:
  • Second trimester (less than 28 weeks)

  • BMI>50

  • Does not wish to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Texas Children's Hospital Pavilion for Women Houston Texas United States 77030

Sponsors and Collaborators

  • Baylor College of Medicine

Investigators

  • Principal Investigator: Leah W Antoniewicz, MD, Baylor College of Medicine

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Leah Antoniewicz, Assistant Professor, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT05260333
Other Study ID Numbers:
  • H-50937
First Posted:
Mar 2, 2022
Last Update Posted:
Aug 15, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Leah Antoniewicz, Assistant Professor, Baylor College of Medicine

Study Results

No Results Posted as of Aug 15, 2022